229 related articles for article (PubMed ID: 30628751)
1. Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children.
Jacobsen LM; Larsson HE; Tamura RN; Vehik K; Clasen J; Sosenko J; Hagopian WA; She JX; Steck AK; Rewers M; Simell O; Toppari J; Veijola R; Ziegler AG; Krischer JP; Akolkar B; Haller MJ;
Pediatr Diabetes; 2019 May; 20(3):263-270. PubMed ID: 30628751
[TBL] [Abstract][Full Text] [Related]
2. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report.
Krischer JP; Liu X; Vehik K; Akolkar B; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Lernmark Å;
Diabetes Care; 2019 Jun; 42(6):1051-1060. PubMed ID: 30967432
[TBL] [Abstract][Full Text] [Related]
3. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA;
Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199
[TBL] [Abstract][Full Text] [Related]
4. Accelerated Progression to Type 1 Diabetes in the Presence of
Balke EM; Balti EV; Van der Auwera B; Weets I; Costa O; Demeester S; Abrams P; Casteels K; Coeckelberghs M; Tenoutasse S; Keymeulen B; Pipeleers DG; Gorus FK;
Diabetes Care; 2018 May; 41(5):1076-1083. PubMed ID: 29545461
[TBL] [Abstract][Full Text] [Related]
5. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years.
Pöllänen PM; Ryhänen SJ; Toppari J; Ilonen J; Vähäsalo P; Veijola R; Siljander H; Knip M
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4638-51. PubMed ID: 32882033
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
[TBL] [Abstract][Full Text] [Related]
8. Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.
Sharma A; Liu X; Hadley D; Hagopian W; Chen WM; Onengut-Gumuscu S; Törn C; Steck AK; Frohnert BI; Rewers M; Ziegler AG; Lernmark Å; Toppari J; Krischer JP; Akolkar B; Rich SS; She JX;
J Autoimmun; 2018 May; 89():90-100. PubMed ID: 29310926
[TBL] [Abstract][Full Text] [Related]
9. Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes.
Triolo TM; Fouts A; Pyle L; Yu L; Gottlieb PA; Steck AK;
Diabetes Care; 2019 Feb; 42(2):192-199. PubMed ID: 30061316
[TBL] [Abstract][Full Text] [Related]
10. The Influence of Type 1 Diabetes Genetic Susceptibility Regions, Age, Sex, and Family History on the Progression From Multiple Autoantibodies to Type 1 Diabetes: A TEDDY Study Report.
Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
Diabetes; 2017 Dec; 66(12):3122-3129. PubMed ID: 28903990
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).
Steck AK; Vehik K; Bonifacio E; Lernmark A; Ziegler AG; Hagopian WA; She J; Simell O; Akolkar B; Krischer J; Schatz D; Rewers MJ;
Diabetes Care; 2015 May; 38(5):808-13. PubMed ID: 25665818
[TBL] [Abstract][Full Text] [Related]
12. Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children.
Ziegler AG; Pflueger M; Winkler C; Achenbach P; Akolkar B; Krischer JP; Bonifacio E
J Autoimmun; 2011 Aug; 37(1):3-7. PubMed ID: 21376535
[TBL] [Abstract][Full Text] [Related]
13. Early childhood CMV infection may decelerate the progression to clinical type 1 diabetes.
Ekman I; Vuorinen T; Knip M; Veijola R; Toppari J; Hyöty H; Kinnunen T; Ilonen J; Lempainen J
Pediatr Diabetes; 2019 Feb; 20(1):73-77. PubMed ID: 30338642
[TBL] [Abstract][Full Text] [Related]
14. Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study.
Beyerlein A; Bonifacio E; Vehik K; Hippich M; Winkler C; Frohnert BI; Steck AK; Hagopian WA; Krischer JP; Lernmark Å; Rewers MJ; She JX; Toppari J; Akolkar B; Rich SS; Ziegler AG;
J Med Genet; 2019 Sep; 56(9):602-605. PubMed ID: 30287597
[TBL] [Abstract][Full Text] [Related]
15. Integration of Infant Metabolite, Genetic, and Islet Autoimmunity Signatures to Predict Type 1 Diabetes by Age 6 Years.
Webb-Robertson BM; Nakayasu ES; Frohnert BI; Bramer LM; Akers SM; Norris JM; Vehik K; Ziegler AG; Metz TO; Rich SS; Rewers MJ
J Clin Endocrinol Metab; 2022 Jul; 107(8):2329-2338. PubMed ID: 35468213
[TBL] [Abstract][Full Text] [Related]
16. Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study.
Törn C; Hadley D; Lee HS; Hagopian W; Lernmark Å; Simell O; Rewers M; Ziegler A; Schatz D; Akolkar B; Onengut-Gumuscu S; Chen WM; Toppari J; Mykkänen J; Ilonen J; Rich SS; She JX; Steck AK; Krischer J;
Diabetes; 2015 May; 64(5):1818-29. PubMed ID: 25422107
[TBL] [Abstract][Full Text] [Related]
17. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.
Jonsdottir B; Larsson C; Lundgren M; Ramelius A; Jönsson I; Larsson HE;
Autoimmunity; 2018 Aug; 51(5):228-237. PubMed ID: 30486698
[TBL] [Abstract][Full Text] [Related]
18. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance.
Redondo MJ; Sosenko J; Libman I; McVean JJF; Tosur M; Atkinson MA; Becker D; Geyer S
J Clin Endocrinol Metab; 2020 May; 105(5):1629-40. PubMed ID: 31867614
[TBL] [Abstract][Full Text] [Related]
19. Predictors of the Initiation of Islet Autoimmunity and Progression to Multiple Autoantibodies and Clinical Diabetes: The TEDDY Study.
Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
Diabetes Care; 2022 Oct; 45(10):2271-2281. PubMed ID: 36150053
[TBL] [Abstract][Full Text] [Related]
20. Evidence of stage- and age-related heterogeneity of non-HLA SNPs and risk of islet autoimmunity and type 1 diabetes: the diabetes autoimmunity study in the young.
Frederiksen BN; Steck AK; Kroehl M; Lamb MM; Wong R; Rewers M; Norris JM
Clin Dev Immunol; 2013; 2013():417657. PubMed ID: 24367383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]